Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03993210 · ClinicalTrials.gov registry record · NA
The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids
A NA study, sponsored by Dana-Farber Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03993210: Clinical Trial NA study, sponsored by Dana-Farber Cancer Institute.
NCT03993210 is a NA study that was terminated before completion, run by Dana-Farber Cancer Institute. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03993210, a NA study, was terminated before completion, sponsored by Dana-Farber Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This research is being done to test new MRI methods called Magnetic Resonance Fingerprinting and Q-space Trajectory Imaging in gynecological abnormalities. The purpose of this research study is to evaluate if these new MRI methods can give additional information in characterizing gynecological tumors compared with conventional MRI.
Primary Outcome
Feasibility is determined by both A) having evaluable images in terms of quality according to radiology review and B) having a complete set of tumor metrics \[MRF (T1 and T2 relaxation values) and QTI (total mean kurtosis MKT, microscopic anisotropy MKA, isotropic heterogeneity MK1, fractional anisotropy FA, microscopic fractional anisotropy µFA)\]
Interventions
- DEVICE Magnetic Resonance Fingerprinting (MRF)
- DEVICE Q-space Trajectory Imaging (QTI)
- DEVICE Magnetic Resonance Imaging Machine (MRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-09-18 |
| Est. Completion | 2019-09-19 |
| Phase | NA |
Why NCT03993210 stopped before completion
NCT03993210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Fingerprinting (MRF) is the first listed.
NCT03993210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03993210 about?
NCT03993210 is a clinical study titled "The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids". This research is being done to test new MRI methods called Magnetic Resonance Fingerprinting and Q-space Trajectory Imaging in gynecological abnormalities. The purpose of this research study is to evaluate if these new MRI methods can give additional information in characterizing gynecological tumor...
What is the current status of trial NCT03993210?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-09-18. Estimated completion is 2019-09-19.
What interventions are being tested in trial NCT03993210?
The interventions under investigation include: Magnetic Resonance Fingerprinting (MRF) (DEVICE), Q-space Trajectory Imaging (QTI) (DEVICE), Magnetic Resonance Imaging Machine (MRI) (DEVICE).
Who is sponsoring clinical trial NCT03993210?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03993210's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI